XELODA 150 (Xeloda 150 mg)

Generic Name: capecitabine

Pill imprint XELODA 150 has been identified as Xeloda 150 mg.

Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; pancreatic cancer; non-small cell lung cancer; breast cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for XELODA 150

Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150
Xeloda
Generic Name:
capecitabine
Imprint:
XELODA
150
Strength:
150 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-1100
Inactive Ingredients:
croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
microcrystalline cellulose
magnesium stearate
water
magnesium silicate
titanium dioxide
ferric oxide red
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4143 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)